|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
281 a.a.
|
 |
|
|
|
|
|
|
|
97 a.a.
|
 |
|
|
|
|
|
|
|
197 a.a.
|
 |
|
|
|
|
|
|
|
240 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of mouse cd1d-alpha-galactosylceramide with mouse valpha14-vbeta7 nkt tcr
|
|
Structure:
|
 |
Antigen-presenting glycoprotein cd1d1. Chain: a. Fragment: extracellular domain. Engineered: yes. Beta-2-microglobulin. Chain: b. Engineered: yes. Valpha14(mouse variable domain, human constant domain). Chain: c.
|
|
Source:
|
 |
Mus musculus. Mouse. Organism_taxid: 10090. Gene: cd1d1, cd1.1. Expressed in: trichoplusia ni. Expression_system_taxid: 7111. Gene: b2m. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.226
|
R-free:
|
0.271
|
|
|
Authors:
|
 |
O.Patel,J.Rossjohn
|
|
Key ref:
|
 |
D.G.Pellicci
et al.
(2009).
Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
Immunity,
31,
47-59.
PubMed id:
|
 |
|
Date:
|
 |
|
08-May-09
|
Release date:
|
28-Jul-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P11609
(CD1D1_MOUSE) -
Antigen-presenting glycoprotein CD1d1 from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
336 a.a.
281 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P01887
(B2MG_MOUSE) -
Beta-2-microglobulin from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
119 a.a.
97 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Immunity
31:47-59
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
|
|
D.G.Pellicci,
O.Patel,
L.Kjer-Nielsen,
S.S.Pang,
L.C.Sullivan,
K.Kyparissoudis,
A.G.Brooks,
H.H.Reid,
S.Gras,
I.S.Lucet,
R.Koh,
M.J.Smyth,
T.Mallevaey,
J.L.Matsuda,
L.Gapin,
J.McCluskey,
D.I.Godfrey,
J.Rossjohn.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The semi-invariant natural killer T cell receptor (NKT TCR) recognizes
CD1d-lipid antigens. Although the TCR alpha chain is typically invariant, the
beta chain expression is more diverse, where three V beta chains are commonly
expressed in mice. We report the structures of V alpha 14-V beta 8.2 and V alpha
14-V beta 7 NKT TCRs in complex with CD1d-alpha-galactosylceramide
(alpha-GalCer) and the 2.5 A structure of the human NKT TCR-CD1d-alpha-GalCer
complex. Both V beta 8.2 and V beta 7 NKT TCRs and the human NKT TCR ligated
CD1d-alpha-GalCer in a similar manner, highlighting the evolutionarily conserved
interaction. However, differences within the V beta domains of the V beta 8.2
and V beta 7 NKT TCR-CD1d complexes resulted in altered TCR beta-CD1d-mediated
contacts and modulated recognition mediated by the invariant alpha chain.
Mutagenesis studies revealed the differing contributions of V beta 8.2 and V
beta 7 residues within the CDR2 beta loop in mediating contacts with CD1d.
Collectively we provide a structural basis for the differential NKT TCR V beta
usage in NKT cells.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Rossjohn,
D.G.Pellicci,
O.Patel,
L.Gapin,
and
D.I.Godfrey
(2012).
Recognition of CD1d-restricted antigens by natural killer T cells.
|
| |
Nat Rev Immunol,
12,
845-857.
|
 |
|
|
|
|
 |
D.Christiansen,
H.A.Vaughan,
J.Milland,
J.Miland,
N.Dodge,
E.Mouhtouris,
M.J.Smyth,
D.I.Godfrey,
and
M.S.Sandrin
(2011).
Antibody responses to glycolipid-borne carbohydrates require CD4+ T cells but not CD1 or NKT cells.
|
| |
Immunol Cell Biol,
89,
502-510.
|
 |
|
|
|
|
 |
E.J.Adams,
and
J.López-Sagaseta
(2011).
The immutable recognition of CD1d.
|
| |
Immunity,
34,
281-283.
|
 |
|
|
|
|
 |
K.S.Wun,
G.Cameron,
O.Patel,
S.S.Pang,
D.G.Pellicci,
L.C.Sullivan,
S.Keshipeddy,
M.H.Young,
A.P.Uldrich,
M.S.Thakur,
S.K.Richardson,
A.R.Howell,
P.A.Illarionov,
A.G.Brooks,
G.S.Besra,
J.McCluskey,
L.Gapin,
S.A.Porcelli,
D.I.Godfrey,
and
J.Rossjohn
(2011).
A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.
|
| |
Immunity,
34,
327-339.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Aspeslagh,
Y.Li,
E.D.Yu,
N.Pauwels,
M.Trappeniers,
E.Girardi,
T.Decruy,
K.Van Beneden,
K.Venken,
M.Drennan,
L.Leybaert,
J.Wang,
R.W.Franck,
S.Van Calenbergh,
D.M.Zajonc,
and
D.Elewaut
(2011).
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.
|
| |
EMBO J,
30,
2294-2305.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Gras,
L.Kjer-Nielsen,
Z.Chen,
J.Rossjohn,
and
J.McCluskey
(2011).
The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection.
|
| |
Immunol Cell Biol,
89,
388-395.
|
 |
|
|
|
|
 |
T.Mallevaey,
A.J.Clarke,
J.P.Scott-Browne,
M.H.Young,
L.C.Roisman,
D.G.Pellicci,
O.Patel,
J.P.Vivian,
J.L.Matsuda,
J.McCluskey,
D.I.Godfrey,
P.Marrack,
J.Rossjohn,
and
L.Gapin
(2011).
A molecular basis for NKT cell recognition of CD1d-self-antigen.
|
| |
Immunity,
34,
315-326.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.A.Sullivan,
N.A.Nagarajan,
G.Wingender,
J.Wang,
I.Scott,
M.Tsuji,
R.W.Franck,
S.A.Porcelli,
D.M.Zajonc,
and
M.Kronenberg
(2010).
Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
|
| |
J Immunol,
184,
141-153.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.I.Godfrey,
J.Rossjohn,
and
J.McCluskey
(2010).
Fighting infection with your MAITs.
|
| |
Nat Immunol,
11,
693-695.
|
 |
|
|
|
|
 |
D.I.Godfrey,
S.Stankovic,
and
A.G.Baxter
(2010).
Raising the NKT cell family.
|
| |
Nat Immunol,
11,
197-206.
|
 |
|
|
|
|
 |
D.J.Baek,
Y.S.Lee,
C.Lim,
D.Lee,
T.Lee,
J.Y.Lee,
K.A.Lee,
W.J.Cho,
C.Y.Kang,
and
S.Kim
(2010).
Rational design and evaluation of a branched-chain-containing glycolipid antigen that binds to CD1d.
|
| |
Chem Asian J,
5,
1560-1564.
|
 |
|
|
|
|
 |
G.Matulis,
J.P.Sanderson,
N.M.Lissin,
M.B.Asparuhova,
G.R.Bommineni,
D.Schümperli,
R.R.Schmidt,
P.M.Villiger,
B.K.Jakobsen,
and
S.D.Gadola
(2010).
Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.
|
| |
PLoS Biol,
8,
e1000402.
|
 |
|
|
|
|
 |
J.J.Miles,
A.M.Bulek,
D.K.Cole,
E.Gostick,
A.J.Schauenburg,
G.Dolton,
V.Venturi,
M.P.Davenport,
M.P.Tan,
S.R.Burrows,
L.Wooldridge,
D.A.Price,
P.J.Rizkallah,
and
A.K.Sewell
(2010).
Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection.
|
| |
PLoS Pathog,
6,
e1001198.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Wang,
Y.Li,
Y.Kinjo,
T.T.Mac,
D.Gibson,
G.F.Painter,
M.Kronenberg,
and
D.M.Zajonc
(2010).
Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells.
|
| |
Proc Natl Acad Sci U S A,
107,
1535-1540.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Gapin
(2010).
iNKT cell autoreactivity: what is 'self' and how is it recognized?
|
| |
Nat Rev Immunol,
10,
272-277.
|
 |
|
|
|
|
 |
M.Salio,
J.D.Silk,
and
V.Cerundolo
(2010).
Recent advances in processing and presentation of CD1 bound lipid antigens.
|
| |
Curr Opin Immunol,
22,
81-88.
|
 |
|
|
|
|
 |
M.Taniguchi,
T.Tashiro,
N.Dashtsoodol,
N.Hongo,
and
H.Watarai
(2010).
The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.
|
| |
Int Immunol,
22,
1-6.
|
 |
|
|
|
|
 |
P.Arrenberg,
R.Halder,
Y.Dai,
I.Maricic,
and
V.Kumar
(2010).
Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.
|
| |
Proc Natl Acad Sci U S A,
107,
10984-10989.
|
 |
|
|
|
|
 |
R.Das,
D.B.Sant'Angelo,
and
K.E.Nichols
(2010).
Transcriptional control of invariant NKT cell development.
|
| |
Immunol Rev,
238,
195-215.
|
 |
|
|
|
|
 |
Y.Li,
E.Girardi,
J.Wang,
E.D.Yu,
G.F.Painter,
M.Kronenberg,
and
D.M.Zajonc
(2010).
The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode.
|
| |
J Exp Med,
207,
2383-2393.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Teyton
(2009).
Natural killer T cell recognition of lipid antigens.
|
| |
F1000 Biol Rep,
1,
0.
|
 |
|
|
|
|
 |
W.C.Florence,
C.Xia,
L.E.Gordy,
W.Chen,
Y.Zhang,
J.Scott-Browne,
Y.Kinjo,
K.O.Yu,
S.Keshipeddy,
D.G.Pellicci,
O.Patel,
L.Kjer-Nielsen,
J.McCluskey,
D.I.Godfrey,
J.Rossjohn,
S.K.Richardson,
S.A.Porcelli,
A.R.Howell,
K.Hayakawa,
L.Gapin,
D.M.Zajonc,
P.G.Wang,
and
S.Joyce
(2009).
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands.
|
| |
EMBO J,
28,
3579-3590.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
| |